Celltrion, Inc. Stock Korea S.E.
Stocks
068270
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - KRW | - |
|
| 07-07 | Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA | MT |
| 07-03 | South Korean Shares Jump on Bargain-Hunting, Chip Stock Gains | MT |
| Market Cap | 39,697B 26.29B 23B 21.21B 19.63B 37.25B 2,510B 37.87B 254B 99.57B 1,232B 98.71B 96.57B 4,269B | P/E 2026 * |
26.8x | P/E 2027 * | 23.7x |
|---|---|---|---|---|---|
| Enterprise Value | 41.74B 27.65M 24.18M 22.3M 20.63M 39.17M 2.64B 39.82M 267M 105M 1.3B 104M 102M 4.49B | EV / Sales 2026 * |
7.88x | EV / Sales 2027 * | 6.65x |
| Free-Float |
58.37% | Yield 2026 * |
0.42% | Yield 2027 * | 0.46% |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 20/03/2015 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 26/03/2021 |
Hyeok-Jae Lee
PSD | President | 50 | 13/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 68 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 01/04/2005 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.68% | +3.19% | +3.55% | +10.22% | 49.42B | |
| +1.63% | +1.74% | +399.82% | +607.57% | 40.34B | |
| +2.23% | +0.51% | +28.44% | -5.16% | 34.01B | |
| +0.74% | +2.18% | +18.94% | +57.96% | 33.56B | |
| -0.19% | +1.02% | - | - | 17.22B | |
| +0.67% | -4.03% | +66.73% | +121.32% | 15.19B | |
| -23.89% | -21.40% | +50.11% | +53.88% | 13.96B | |
| +2.59% | -0.49% | +15.24% | +20.83% | 13.36B | |
| +1.28% | -3.04% | +11.47% | -31.32% | 12.68B | |
| Average | -1.49% | +0.86% | +74.29% | +104.41% | 25.53B | |
| Weighted average by Cap. | -0.14% | +1.32% | +93.97% | +137.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,293B 3.51B 3.07B 2.83B 2.62B 4.97B 335B 5.05B 33.87B 13.28B 164B 13.16B 12.88B 569B | 6,181B 4.09B 3.58B 3.3B 3.06B 5.8B 391B 5.9B 39.55B 15.5B 192B 15.37B 15.04B 665B |
| Net income | 1,518B 1.01B 879M 811M 750M 1.42B 95.95B 1.45B 9.71B 3.81B 47.12B 3.77B 3.69B 163B | 1,698B 1.12B 984M 907M 840M 1.59B 107B 1.62B 10.87B 4.26B 52.72B 4.22B 4.13B 183B |
| Net Debt | 2,041B 1.35B 1.18B 1.09B 1.01B 1.92B 129B 1.95B 13.06B 5.12B 63.38B 5.08B 4.97B 220B | 1,427B 945M 827M 763M 706M 1.34B 90.25B 1.36B 9.13B 3.58B 44.32B 3.55B 3.47B 154B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- A068270 Stock
- 068270 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
